NYSE:VSI - Vitamin Shoppe Stock Price, News & Analysis

$7.22
+0.02 (+0.28 %)
(As of 09/17/2019 04:36 AM ET)
Today's Range
$7.15
Now: $7.22
$7.34
50-Day Range
$4.17
MA: $6.08
$7.31
52-Week Range
$3.32
Now: $7.22
$12.65
Volume203,700 shs
Average Volume591,573 shs
Market Capitalization$173.73 million
P/E Ratio27.77
Dividend YieldN/A
Beta1.55
Vitamin Shoppe, Inc, through its subsidiaries, operates as a omni-channel specialty retailer and contract manufacturer of nutritional products in the United States and internationally. It operates in two segments, Retail and Manufacturing. The company provides custom manufacturing and private labeling services for vitamin, mineral, and supplement products, as well as develops and markets own branded products. Read More…

Industry, Sector and Symbol

Industry Food stores
Sub-IndustrySpecialty Stores
SectorRetail/Wholesale
CUSIP92849E10
Phone201-868-5959

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$1.11 billion
Cash Flow$2.4558 per share
Book Value$7.85 per share

Profitability

Net Income$-3,750,000.00

Miscellaneous

Employees5,136
Market Cap$173.73 million
Next Earnings Date11/6/2019 (Estimated)
OptionableOptionable

Receive VSI News and Ratings via Email

Sign-up to receive the latest news and ratings for VSI and its competitors with MarketBeat's FREE daily newsletter.


Vitamin Shoppe (NYSE:VSI) Frequently Asked Questions

What is Vitamin Shoppe's stock symbol?

Vitamin Shoppe trades on the New York Stock Exchange (NYSE) under the ticker symbol "VSI."

How were Vitamin Shoppe's earnings last quarter?

Vitamin Shoppe Inc (NYSE:VSI) issued its earnings results on Thursday, August, 8th. The specialty retailer reported $0.20 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.12 by $0.08. The specialty retailer earned $270.88 million during the quarter, compared to analysts' expectations of $278.60 million. Vitamin Shoppe had a positive return on equity of 3.34% and a negative net margin of 0.66%. View Vitamin Shoppe's Earnings History.

When is Vitamin Shoppe's next earnings date?

Vitamin Shoppe is scheduled to release their next quarterly earnings announcement on Wednesday, November 6th 2019. View Earnings Estimates for Vitamin Shoppe.

What price target have analysts set for VSI?

3 brokerages have issued twelve-month price targets for Vitamin Shoppe's shares. Their forecasts range from $4.00 to $14.00. On average, they expect Vitamin Shoppe's share price to reach $9.00 in the next year. This suggests a possible upside of 24.7% from the stock's current price. View Analyst Price Targets for Vitamin Shoppe.

What is the consensus analysts' recommendation for Vitamin Shoppe?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Vitamin Shoppe in the last year. There are currently 3 hold ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Vitamin Shoppe.

Has Vitamin Shoppe been receiving favorable news coverage?

News stories about VSI stock have been trending somewhat positive this week, InfoTrie Sentiment Analysis reports. The research group scores the sentiment of media coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Vitamin Shoppe earned a coverage optimism score of 0.9 on InfoTrie's scale. They also assigned news articles about the specialty retailer a news buzz of 1.0 out of 10, meaning that recent media coverage is extremely unlikely to have an impact on the company's share price in the next several days. View News Stories for Vitamin Shoppe.

Are investors shorting Vitamin Shoppe?

Vitamin Shoppe saw a decrease in short interest during the month of August. As of August 31st, there was short interest totalling 5,154,700 shares, a decrease of 23.0% from the July 31st total of 6,693,600 shares. Based on an average daily trading volume, of 727,100 shares, the short-interest ratio is presently 7.1 days. Approximately 26.2% of the company's stock are short sold. View Vitamin Shoppe's Current Options Chain.

Who are some of Vitamin Shoppe's key competitors?

What other stocks do shareholders of Vitamin Shoppe own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Vitamin Shoppe investors own include GNC (GNC), Costco Wholesale (COST), salesforce.com (CRM), Transocean (RIG), General Electric (GE), BGC Partners (BGCP), Cisco Systems (CSCO), Groupon (GRPN), NVIDIA (NVDA) and Sirius XM (SIRI).

Who are Vitamin Shoppe's key executives?

Vitamin Shoppe's management team includes the folowing people:
  • Mr. David M. Kastin, Sr. VP, Gen. Counsel & Corp. Sec. (Age 51)
  • Ms. Sharon M. Leite, CEO & Director (Age 56)
  • Mr. Charles D. Knight, Interim CFO, Sr. VP & Chief Accounting Officer (Age 55)
  • Mr. Andrew Laudato, CTO & Exec. VP (Age 52)
  • Mr. David Morrison, VP of Scientific & Regulatory Affairs

Who are Vitamin Shoppe's major shareholders?

Vitamin Shoppe's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include VIEX Capital Advisors LLC (9.16%), Vanguard Group Inc. (7.54%), BlackRock Inc. (6.92%), Invesco Ltd. (4.34%), Connor Clark & Lunn Investment Management Ltd. (2.36%) and D. E. Shaw & Co. Inc. (1.44%). Company insiders that own Vitamin Shoppe stock include Alex Smith, Guillermo Marmol, Shah Capital Management, Sharon M Leite and Vintage Capital Management Llc. View Institutional Ownership Trends for Vitamin Shoppe.

Which institutional investors are selling Vitamin Shoppe stock?

VSI stock was sold by a variety of institutional investors in the last quarter, including D. E. Shaw & Co. Inc., Renaissance Technologies LLC, Bank of New York Mellon Corp, Systematic Financial Management LP, Morgan Stanley, Hancock Whitney Corp, Parametric Portfolio Associates LLC and Connor Clark & Lunn Investment Management Ltd.. View Insider Buying and Selling for Vitamin Shoppe.

Which institutional investors are buying Vitamin Shoppe stock?

VSI stock was bought by a variety of institutional investors in the last quarter, including VIEX Capital Advisors LLC, Invesco Ltd., Charles Schwab Investment Management Inc., Menta Capital LLC, Municipal Employees Retirement System of Michigan, Alpha Windward LLC, Vanguard Group Inc. and Crestline Management LP. Company insiders that have bought Vitamin Shoppe stock in the last two years include Alex Smith, Guillermo Marmol, Shah Capital Management, Sharon M Leite and Vintage Capital Management Llc. View Insider Buying and Selling for Vitamin Shoppe.

How do I buy shares of Vitamin Shoppe?

Shares of VSI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Vitamin Shoppe's stock price today?

One share of VSI stock can currently be purchased for approximately $7.22.

How big of a company is Vitamin Shoppe?

Vitamin Shoppe has a market capitalization of $173.73 million and generates $1.11 billion in revenue each year. The specialty retailer earns $-3,750,000.00 in net income (profit) each year or $0.26 on an earnings per share basis. Vitamin Shoppe employs 5,136 workers across the globe.View Additional Information About Vitamin Shoppe.

What is Vitamin Shoppe's official website?

The official website for Vitamin Shoppe is http://www.vitaminshoppe.com/.

How can I contact Vitamin Shoppe?

Vitamin Shoppe's mailing address is 300 HARMON MEADOW BLVD., SECAUCUS NJ, 07094. The specialty retailer can be reached via phone at 201-868-5959 or via email at [email protected]


MarketBeat Community Rating for Vitamin Shoppe (NYSE VSI)

Community Ranking:  2.0 out of 5 (star star)
Outperform Votes:  352 (Vote Outperform)
Underperform Votes:  517 (Vote Underperform)
Total Votes:  869
MarketBeat's community ratings are surveys of what our community members think about Vitamin Shoppe and other stocks. Vote "Outperform" if you believe VSI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe VSI will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 9/17/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel